Keyphrases
Germ Cells
65%
Multiple Primary Melanoma
49%
TINF2
49%
Susceptibility Genes
49%
Chronic Rhinosinusitis
49%
Somatic mutation
49%
Pathogenic Variants
49%
BRCA1-associated Protein 1 (BAP1)
49%
Uveal Melanoma
49%
Multiple Primary Cancers
49%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
49%
9p21
49%
Microdeletion
49%
Young Patients
49%
BAP1 mutation
39%
Tumor
39%
Melanoma
30%
Metastasis
29%
CDKN2B
29%
Treatment Effect
24%
Sniffin' Sticks
24%
Comorbidity
24%
Diagnostic Criteria
24%
Steroid Irrigation
24%
Diagnosis Treatment
24%
Further Treatment
24%
Systemic Antibiotics
24%
Nasal Irrigation
24%
Systemic Steroids
24%
Sino-Nasal Outcome Test
24%
Allergy
24%
Topical Steroids
24%
Visual Analog Scale
24%
Unified Airway
24%
Additional Treatment
24%
Current Guidelines
24%
Treatment Risk
24%
Treatment Options
24%
Test Use
24%
Initial Treatment
24%
Serum IgE
24%
Cancer Predisposition Syndrome
23%
Observation Time
19%
Extraskeletal Osteosarcoma
19%
Thyroid Cancer
14%
Cancer Types
14%
Genetic Analysis
9%
Splice Variant
9%
Tumor Samples
9%
Overall Survival
9%
Medicine and Dentistry
Chronic Rhinosinusitis
49%
Uvea Melanoma
49%
Osteosarcoma
49%
Proteus Syndrome
49%
Malignant Neoplasm
49%
Immunoglobulin E
24%
Biopsy
24%
Nasal Irrigation
24%
Topical Corticosteroid
24%
Treatment Effect
24%
Antibiotics
24%
Visual Analog Scale
24%
Diagnosis
24%
Neural System
24%
Haploinsufficiency
24%
Cancer Susceptibility
24%
Clear Cell Renal Cell Carcinoma
24%
Gene Deletion
24%
Neoplasm
24%
Primary Tumor
24%
Pancreas Cancer
24%
Nodular Melanoma
24%
Biochemistry, Genetics and Molecular Biology
Germ Cell
100%
Germline
100%
TINF2
49%
BAP1
49%
Somatic Mutation
49%
CDKN2B
49%
Telomere
21%
Gene Deletion
12%
Haploinsufficiency
12%
Telomere Length
7%
Monozygotic Twins
7%
Lifespan
7%
Telomere Homeostasis
7%
Shelterin
7%
POT1
7%
Clinical Study
7%
Overall Survival
5%
Genetics
5%
